scispace - formally typeset
R

Rachid Drissi

Researcher at Cincinnati Children's Hospital Medical Center

Publications -  52
Citations -  3509

Rachid Drissi is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Medicine & Cancer research. The author has an hindex of 17, co-authored 36 publications receiving 2689 citations. Previous affiliations of Rachid Drissi include University of Cincinnati Academic Health Center & Ohio State University.

Papers
More filters
Journal ArticleDOI

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Dominik Sturm, +82 more
- 16 Oct 2012 - 
TL;DR: It is demonstrated that each H3F3A mutation defines an epigenetic subgroup of GBM with a distinct global methylation pattern, and that they are mutually exclusive with IDH1 mutations, which characterize a third mutation-defined subgroup.
Journal ArticleDOI

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Dominik Sturm, +122 more
- 25 Feb 2016 - 
TL;DR: It is demonstrated that a significant proportion of institutionally diagnosed CNS-PNETs display molecular profiles indistinguishable from those of various other well-defined CNS tumor entities, facilitating diagnosis and appropriate therapy for patients with these tumors.
Journal ArticleDOI

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.

Lindsey M. Hoffman, +79 more
TL;DR: Clinical, radiologic, and molecular factors that correlate with survival in children and young adults with DIPG are reported, which are important for risk stratification in future clinical trials.
Journal ArticleDOI

Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics

TL;DR: Spatial conservation of prognostically-relevant and therapeutically-targetable somatic mutations in DIPG and mHGG contrasts the significant heterogeneity of driver mutations seen in adult HGG and supports uniform implementation of diagnostic biopsy in DISPs to classify molecular risk groups and guide therapeutic strategy.